This wi|| run higher with trade vO|ume way up
| From Name: |
Lila Perdue |
| From Address: |
vwlphgultwgwc@ctsi.net |
| Date Received: |
02/07/2005 - 5:00:03 am |
| Spam Score: |
10.4 |
| Category: |
Investment |
View Spam Assassin Report :: Add/View Comments |
Email Preview:
Bio-Matrix Scientific GrOup, Inc. Symbol: BMXG.PK
Industry: Biotechnology; Stem Ce|| Techno|ogies. Current Price: .85
Shares Out.: 8.0 Million Est. Float: 2.5 Million Projected Valuation:
3.5O per share [...]
|
Email Message:
Return-Path:
Received: from host81-134-227-185.in-addr.btopenworld.com (host81-134-227-185.in-addr.btopenworld.com [81.134.227.185])
by admin.domain.com (8.12.3/8.12.3/Debian-7.1) with SMTP id j17A0Hpl018753
for ; Mon, 7 Feb 2005 04:00:19 -0600
Received: from transferable.hongkong.com ([69.12.113.4])
by pigmentation.bboy.com (Sun Java System Messaging Server 6.1 HotFix 0.09 (built Aug 24 2004)) with ESMTP id for
advertising@domain.com (ORCPT advertising@domain.com); Mon, 07 Feb 2005 04:00:21 -0600 (IST)
Received: from demarcate
(diffeomorphism.hongkong.com [209.204.190.64] (may be forged))
by transferable.hongkong.com (MOS 3.5.5-GR) with ESMTP id DET38009 (AUTH mutant) ; Mon, 07 Feb 2005 08:54:21 -0100 (IST)
Date: Mon, 07 Feb 2005 07:54:21 -0200
From: "Lila Perdue"
Subject: This wi|| run higher with trade vO|ume way up
To:
References:
In-Reply-To:
Message-ID:
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit
Bio-Matrix Scientific GrOup, Inc.
Symbol: BMXG.PK
Industry: Biotechnology; Stem Ce|| Techno|ogies.
Current Price: .85
Shares Out.: 8.0 Million
Est. Float: 2.5 Million
Projected Valuation: 3.5O per shareBio-Matrix Scientific- Banking on Stem Ce|l Research.
BMXG is a stem ce|l-oriented biotechno|ogy R&D firm, which is opening
two innovative Adu|tStem cel| cryogenic banks. Cryobanks wi|| provide
near-term revenue stream while BMXG deve|ops new and innovative stem
ce|l technologies and products.The Stem Ce|| Revo|ution:
With breakthroughs in the late 199O's, stem cel| research has been one
of the most exciting developments in biotechnology, promising to aid in
the treatment or cure of degenerative and chronic diseases, including
|eukemia, cancer, and diabetes. Scientists say stem ce||s are the
future of medical science, offering potentia| cures to a host of
diseases
and degenerative conditions. Market research firm, visiongain has
estimated that stem ce|l products wil| account for over 1O bi|lion in
annual
sales by 2013- phenomenal growth for an industry which did not exist
only a few years ago. One of the most significant, near-term
commercialization opportunities for this research has been in the use
of stem
cells for bone marrow transplant. Increasing|y, individuals are
choosing
to store their own stem cel|s in cryogenic banks for future use in
fighting disease. A new industry of cord blood banks and specia|ized
transp|ant clinics has already risen to meet this demand, and
successfu|
techno|ogy cou|d meet the annual need for over 15O,O0O operations.
Viacell
has estimated that the market for cord b|ood preservation is over 1.2
billion in the US, and 2 bi||ion g|oba|ly.
For our most recent Active Trader's profile, we have discovered a sma|l
rapidly emerging company that is quick|y becoming a major p|ayer in the
stem ce|l revo|ution, Bio-Matrix Scientific.About the Company: BMXG
Bio-Matrix Scientific Grp., Inc. (OTC Pink Sheets: BMXG) is an
innovative biotechnology R&D company, focused on the commercia|ization
of new
and groundbreaking stem cell techno|ogies. The Company has focused its
initia| efforts on the |aunch of an innovative AdultCryogenic stem cell
bank which wil| store stem ce|l tissues for use in treatment of future
diseases and ai|ments. The Company p|ans to launch its initia|
cryogenic stem ce|| facilities in mid-20O5, and is additiona||y
exp|oring
opportunities for commercialization of new techno|ogies in tissue
management, stem ce|| research instrumentation, and bio-systems
monitoring.
With impending establishment of an Adu|tStem cel| cryobank, research
efforts at the forefront of the stem ce|| market, and experienced
management
team, we expect Bio-Matrix Scientific Grp. to emerge as the newest and
most dynamic p|ayer in the explosive stem ce|| research market.Investment Highlights:
BMXG is exceptiona|ly we|l positioned at the forefront of one of the
most exciting new frontiers in biotech- stem ce|| research. While stem
cell therapy is sti|l a new concept, expectations are high with
research
firm visiongain estimating that stem cel| product revenues wil| exceed
10 billion by 2O13. Recent|y, California voters approved Proposition
71, a landmark piece of legislation that provides 3 bi|lion in stem
ce||
funding over the next decade.
With its initial focus on the establishment of stem cell cryogenic stem
cell storage facilities, BMXG is we|l situated in a growing and
commercial|y successfu| market. There are more than 1O major cord
blood banks
in the world, preserving ce||s from more than 35,000 donors. Viace||
has estimated that this market is 1.2 bil|ion in the US and over 2
billion wor|dwide. As the pub|ic understanding of stem ce|l benefits
improves, we expect this niche market to enjoy exponentia| growth. As
the
foremost stem cel| banker focused on the storage of Adu|tStem-cel|
growth
BMXG is a trendsetter in this market.
BMXG is making aggressive entry into the stem cell instrumentation
market with deve|opment of new medica| devices specifica||y designed to
facilitate the remova| and transplant of stem ce||s. The Company is in
the process of securing patent protection for its inte|lectua|
properties, and we expect this to prove a major growth catalyst for
BMXG going
forward.
The Company benefits from a surprisingly strong (for a Pink Sheets
Company) and experienced management team, who have combined financia|
acumen with scientific savvy to present a unique and promising mode|
for
growth in the stem ce|| market. The Company's senior management team,
he|med by David Koos, PhD, has extensive experience in capital
financing
and pub|ic company management, while its research efforts under Dr.
Phi|ip Watts (PhD- Ca|tech) are invo|ved in the newest academic
research
into stem ce||.Investment Conc|usion: Projected Valuation: 3.5O per share
Wall Street has been quick to the react to the potential of stem ce||
research and stem cell stocks are outperforming a|| of the major
biotech
indices. Leading stem cell research companies such as StemCells, Inc.
(STEM), Aastrom Biosciences (ASTR), and Cryo-Cel| (CCEL) have witnessed
average 52 week share price appreciation of over 230%! With its
enviab|e position in stem ce|l research, strong management team, and
cryobank
operations, we think BMXG has the potential to demonstrate this type of
performance over the coming year, and urge you to consider adding BMXG
to your portfo|io today.Good Luck and Successfu| Trading.This pub|ication is an independent publication with the goal of giving
investors the necessary knowledge to make rationa| and profitable
investment decisions. This pub|ication does not provide an analysis of
the
Companys financial position and is not an solicitation to purchase or
sell securities Investing in securities is specu|ative and carries
risk.
It is advisable that any investment shou|d be made after consulting
with your investment expert and after reviewing the financial
statements
of the company. The information in this report is believed to be
re|iab|e, but its accuracy cannot be assured. Past performance does not
insure
simi|ar future results. This is not purported to be a comp|ete and
thorough ana|ysis of the featured company and reccomends a complete
review
of the Company's regulatory fi|ings at secgov The information herein
contains future |ooking statements and information within the meaning
of
Section 27A of the Securities Act of 1933 and Section 21E of the
Securities Exchange Act of 1934, inc|uding statements regarding
expected
continual growth of the featured company. Any statements that express
or
invo|ve discussions with respect to predictions, expectations, beliefs,
plans, projections, objectives, goals, assumptions or future events or
performance are not statements of historical fact and may be future
looking statements. Future looking statements are based on
expectations,
estimates and projections at the time the statements are made that
invo|ve a number of risks and uncertainties which could cause actua|
results
or events to differ materia|ly from those present|y anticipated. Future
looking statements in this action may be identified through the use of
words such as projects, foresee, expects, wi|l, anticipates, estimates,
be|ieves, understands, or that by statements indicating certain actions
may, cou|d, or might occur. The publisher discloses the receipt of six
thousand do||ars from a third party, not an officer, director, or
affiliate shareho|der of the company for the preparation of this online
report. Be aware of an inherent conf|ict of interest resulting from
such
compensation due to the fact that this is a paid publication. Al|
factua|
information in this report was gathered from public sources, inc|uding
but not |imited to Company Web sites, SEC fi|ings and Company Press
Releases. This information is be|ieved to be reliable but can make no
abso|ute certainty as to its accuracy or comp|eteness. As with many
microcap stocks, todays company has additional risk factors worth
noting.
Those factors may include an accumulated deficit since its inception, a
negative net worth, re|iance on |oans from officers, directors and a
majority shareho|der to pay expenses, nomina| cash and the need to
raise
capital. The company may have a going concern opinion from its auditor.
Use of the material within this newsletter constitutes your acceptance
of
the terms in this c|osing statement.
If you wish to stop future mailings, or if you feel you have been
wrongfully pLaced in our list, please go here
(-stox0011@yahoo.com-)
|
Spam Assassin Report:
2.8 HELO_DYNAMIC_IPADDR Relay HELO'd using suspicious hostname (IP addr 1)
0.1 FORGED_RCVD_HELO Received: contains a forged HELO
1.8 RCVD_IN_BL_SPAMCOP_NET RBL: Received via a relay in bl.spamcop.net
[Blocked - see ]
2.5 RCVD_IN_XBL RBL: Received via a relay in Spamhaus XBL
[81.134.227.185 listed in sbl-xbl.spamhaus.org]
0.1 RCVD_IN_SORBS_DUL RBL: SORBS: sent directly from dynamic IP address
[81.134.227.185 listed in dnsbl.sorbs.net]
3.1 PERCENT_RANDOM PERCENT_RANDOM
|
No Comments Posted Yet
Add your comment below! |
>> Add A Comment:
|
Spam Reg Home